TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
An analysis of data from 91,339 participants in nine clinical trials found that blood-pressure treatment was associated with stronger cardiovascular protection among people who took at least 80% of their assigned medication. In the lower-adherence group, researchers found no statistically significant reduction in major cardiovascular events; the analysis does not prove that missed doses alone caused the difference.
Researchers analyzing 91,339 participants in nine clinical trials found that blood-pressure treatment was associated with greater reductions in major cardiovascular events among people who took at least 80% of their assigned medication than among those with lower adherence. Presented at ESC Congress 2026, the analysis found no statistically significant reduction in those events in the lower-adherence group, underscoring how missed doses may weaken treatment benefits.
The researchers compared participants assigned to a blood-pressure treatment with those assigned to a comparator, which was either a placebo or a less-intensive treatment regimen. They classified people as having higher adherence if they took at least 80% of their assigned medication; taking less than 80% placed them in the lower-adherence group. The analysis pooled individual patient data from nine trials, rather than relying only on comparisons between separate studies.
Among participants in the higher-adherence group, systolic blood pressure—the top number in a reading—was 5.2 mmHg lower in the intervention group than in the comparator group. In the lower-adherence group, the difference was 3.0 mmHg. Researchers also examined major cardiovascular events, including stroke, heart attack, ischemic heart disease, and heart failure leading to hospitalization or death.
For participants with higher adherence, the intervention group had an 11% lower incidence of major cardiovascular events than the comparator group. In the lower-adherence group, researchers found no statistically significant reduction. Adherence also declined over time: 88% met the higher threshold in year one, compared with 79% by year five, even within the structured environment of clinical trials.
Adherence Affected Measured Protection
The findings matter because medicines that lower blood pressure are used to reduce risks that include heart attack and stroke, but their benefit depends in part on patients taking them as prescribed. The analysis suggests that lower adherence may be associated with a smaller treatment effect, both on blood pressure readings and on major cardiovascular outcomes.
The distinction is not that every missed dose will cause a cardiovascular event. The study grouped people by their overall adherence and compared treatment with a comparator; it did not establish the effect of any single missed pill. Still, the results point to adherence as a potential part of explaining why prescribed treatment may not produce its expected benefit for some patients. Researchers said regular, non-judgmental discussions about barriers could help care teams identify practical ways to support consistent use.
Products Worth Considering
OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG
OMRON VIVA 360+ Body Composition Monitor and Smart Scale
Oura Ring 4 Smart Ring – Silver – Size 8
As an affiliate, we earn on qualifying purchases.
Nine Trials, One Adherence Analysis
High blood pressure, also called hypertension, is a major contributor to illness and death. The source report estimates that 1.4 billion adults aged 30 to 79 worldwide have the condition. Blood-pressure-lowering medicines are established treatments for reducing cardiovascular risk, while the report says about half of patients do not take their prescriptions as directed.
Presenter Miss Qianqian Yang of the University of Oxford said earlier evidence linking poor adherence to worse outcomes came from observational studies, which can be affected by other differences between patients. The team used individual data from randomized trials to examine whether adherence was associated with the benefits of treatment. Trial conditions included structured monitoring, yet the share meeting the higher-adherence threshold fell over the years examined.
“A decline in adherence over time was apparent, even in the structured setting of trials.”
— Miss Qianqian Yang
Limits of the Findings
The results show differences between adherence groups, but the source report does not establish that missed doses alone caused the difference in cardiovascular outcomes. Adherence was categorized using a threshold of 80% of assigned medication; the summary does not specify how adherence was measured across all trials or how the analysis addressed every possible difference between people in the two adherence groups.
The lower-adherence group had no statistically significant reduction in major cardiovascular events. That finding does not prove treatment had no effect for every participant; it means the analysis did not find a statistically significant reduction in that group. The report also does not provide the absolute event rates, confidence intervals, or a breakdown of results by medication type, individual trial, or specific cause of missed doses.
Making Daily Treatment Easier
The researchers recommend that clinicians make routine adherence assessments part of hypertension care and use patient education and practical support to address barriers. Possible approaches cited in the report include simplifying dosing schedules, combining multiple treatments in one pill, and using longer-acting drugs that may limit the consequences of an occasional missed dose.
Mahfoud said clinicians should have open, non-judgmental conversations with patients about difficulties taking medication. The report does not describe a new intervention trial or a change to treatment guidelines. Further details on the analysis, including how adherence was measured and the full statistical results, would help clarify how the findings should guide care.
Key Questions
What did the analysis find about missed blood-pressure medication?
Across nine trials, participants who took at least 80% of assigned medication had a larger treatment-related reduction in systolic blood pressure and an 11% lower incidence of major cardiovascular events compared with their trial comparators. The lower-adherence group had no statistically significant reduction in events.
Does one missed dose cause a heart attack or stroke?
The analysis does not establish that a single missed dose causes a cardiovascular event. It compared outcomes across groups classified by their overall adherence, so its findings concern patterns of medication use, not the effect of one particular missed dose.
How did the researchers define higher adherence?
Participants were classified as having higher adherence if they took 80% or more of their assigned medication. Those taking less than 80% were placed in the lower-adherence group.
What can patients do if they have trouble taking their medication?
The researchers recommend discussing barriers with a healthcare professional. They cite options such as simplifying the schedule or combining medicines in one pill, but treatment changes should be discussed with a qualified clinician rather than made independently.
Source: rss
